The number of people with susceptibility test result for rifampicin in Guinea-Bissau

Guinea-Bissau: The number of people with susceptibility test result for rifampicin was 1,934 in 2021. ◆ Volatile

Latest (2021)
1,934
Change on year
up 59.6%
World rank
48th
of 155 countries
All-time high
1,934
in 2021
All-time low
0
in 2017
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Guinea-Bissau, 2017–2021

05001.0k1.5k2.0k2017201920212017: 02018: 452019: 172020: 1.2k2021: 1.9k

Source: World Health Organization, Global Health Observatory.

Analysis

Guinea-Bissau recorded 1,934 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.

Compared with earlier readings it is up 59.6% on the previous year.

That places Guinea-Bissau 48th out of 155 countries with data for 2021, putting it in the middle of the range.

The number of people with susceptibility test result for rifampicin in Guinea-Bissau, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Guinea-Bissau, 2017 to 2021.
Year Value Change
2017 0
2018 45
2019 17 -62.2%
2020 1,212 +7029.4%
2021 1,934 +59.6%

Guinea-Bissau compared with similar countries

  • Guinea-Bissau's 1,934 is above the median for low income countries, which is 1,934, 1.0× the median. (15 countries reporting)
  • Guinea-Bissau's 1,934 is below the median for Sub-Saharan Africa, which is 2,015, 96% of the median. (33 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 20.67 0 45 3
2020s 1,573 1,212 1,934 2

Countries ranked near Guinea-Bissau

  1. 45 Hong Kong, China 2,181 compare
  2. 46 Guatemala 2,022 compare
  3. 47 Congo 2,015 compare
  4. 49 Kyrgyzstan 1,932 compare
  5. 50 Tajikistan 1,862 compare
  6. 51 Iran, Islamic Republic of 1,828 compare

See the full ranking of 157 places →

More health data for Guinea-Bissau

All data for Guinea-Bissau →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Guinea-Bissau?
The number of people with susceptibility test result for rifampicin in Guinea-Bissau was 1,934 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Guinea-Bissau?
The highest recorded value was 1,934 in 2021.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Guinea-Bissau?
The lowest recorded value was 0 in 2017.
How does Guinea-Bissau rank for the number of people with susceptibility test result for rifampicin?
Guinea-Bissau ranks 48th out of 155 countries with data for 2021.
Where does this Guinea-Bissau data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Guinea-Bissau. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/guinea-bissau/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/guinea-bissau/">The number of people with susceptibility test result for rifampicin in Guinea-Bissau</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed